This information constitutes forward-looking statements relating to the
business of Legend Biotech USA Inc. (“Legend”), including express or
implied discussions regarding potential new products, potential new
indications, or regarding potential future revenues from any such
products. Such forward-looking statements reflect the current views
of Legend’s management regarding future events, and involve known and
unknown risks, uncertainties, and other factors that may cause actual
results to be materially different from any future results, performance
or achievements expressed or implied by such statements.
The safety and efficacy of the agents and/or uses under investigation have
not been established. There is no guarantee that the agents will receive
health authority approval or become commercially available in any country
for the uses being investigated or that such agents as products will achieve any particular revenue levels.
This information was factually accurate on the date it was published.
Legend assumes no duty to update the information to reflect subsequent
developments. Readers should not rely upon the information on this page
as current or accurate after its publication date.
In particular, Legend’s expectations could be affected by, among other
things, uncertainties involved in the development of new pharmaceutical
products; unexpected clinical trial results, including additional
analysis of existing clinical data or unexpected new clinical data;
unexpected regulatory actions or delays or government regulation generally;
Legend’s ability to obtain or maintain patent or other proprietary
intellectual property protection, including the uncertainties involved
in the US litigation process; competition in general; government,
industry, and general public pricing and other political pressures.
Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual results may vary
materially from those described herein as anticipated, believed, estimated,